Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 024624/0566 | |
| Pages: | 8 |
| | Recorded: | 06/29/2010 | | |
| Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12203321
|
Filing Dt:
|
09/03/2008
|
|
Publication #:
|
|
Pub Dt:
|
03/05/2009
| | | | |
|
Title:
|
COMBINATION THERAPY WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12234739
|
Filing Dt:
|
09/22/2008
|
|
Publication #:
|
|
Pub Dt:
|
04/16/2009
| | | | |
|
Title:
|
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12234759
|
Filing Dt:
|
09/22/2008
|
|
Publication #:
|
|
Pub Dt:
|
04/30/2009
| | | | |
|
Title:
|
COMBINATION THERAPY OF TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12408746
|
Filing Dt:
|
03/23/2009
|
|
Publication #:
|
|
Pub Dt:
|
10/01/2009
| | | | |
|
Title:
|
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
|
|
|
Assignee
|
|
|
|
|
| WAGISTRASSE 18 |
| A SWISS COMPANY |
| CH-8952 SCHLIEREN, SWITZERLAND |
|
|
Correspondence name and address
|
| |
GEORGE W. JOHNSTON
|
| |
HOFFMANN-LA ROCHE INC.
|
| |
PATENT LAW DEPARTMENT
|
| |
340 KINGSLAND STREET
|
| |
NUTLEY, NJ 07110
|
Search Results as of:
06/07/2024 05:01 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
